About ME/CFS
Complex I Respiratory Chain Protocol

Sublingual NADH & CoQ10 Synergy: Cellular ATP Protocol

Complex I electron donation, sublingual venous absorption vs. gastric acid breakdown, clinical trial benchmarks, and an interactive morning wake-up dosing scheduler for ME/CFS.

The Two-Part Bioenergetic Handshake

Cellular respiration requires a seamless electron relay. NADH provides high-energy electrons to Complex I (NADH:ubiquinone oxidoreductase), pumping protons across the inner mitochondrial membrane. CoQ10 acts as the physical mobile shuttle, accepting those electrons and transferring them to Complex III. Prescribing CoQ10 without NADH starves the entry port of electrons; prescribing NADH without adequate CoQ10 creates a bottleneck that generates superoxide free radicals. Combining both agents simultaneously unblocks oxidative phosphorylation PMID: 25386668.

Mechanism of Action: Overcoming Complex I Suppression

Multiple independent metabolomic studies (Naviaux et al., Fluge & Mella, Sweetman et al.) demonstrate that ME/CFS cells reside in a hypometabolic state akin to dauer/hibernation, marked by suppressed Complex I activity and an inverted NAD+/NADH ratio.

1. Sublingual Absorption Kinetics

NADH is an extremely sensitive dinucleotide molecule. Swallowed capsules are exposed to gastric acid (pH 1.5–2.0), which destroys the reduced dihydropyridine ring within 60 seconds.

  • Sublingual Direct Uptake: Dissolving under the tongue bypasses the stomach entirely, entering the lingual and sublingual veins directly into the superior vena cava.
  • Stabilized Enada Matrix: Utilizes sodium bicarbonate buffers and chlorophyll stabilizers to prevent degradation upon atmospheric moisture contact.

2. Neurotransmitter Biosynthesis

Beyond the mitochondria, NADH is an essential cofactor for tyrosine hydroxylase and tryptophan hydroxylase:

  • Dopamine & Norepinephrine: Recharges tetrahydrobiopterin (BH4), the rate-limiting cofactor for catecholamine synthesis, alleviating orthostatic brain fog.
  • Serotonin Production: Enhances central monoamine neurotransmission, mitigating autonomic sleep dysregulation and post-viral anhedonia.
🔋

NADH + CoQ10 Synergistic Dosing & Regimen Scheduler

Calculate the combined bioenergetic synergy score and generate a strict morning wake-up countdown schedule based on clinical trial standards.

Bioenergetic Synergy
92 / 100
Trial Benchmark
Barcelona RCT Match
Morning Wakeup Lead
T - 30 Minutes
Clinical Indication
Full Complex I Unblocking

Morning Administration Protocol Timeline

Timeline Milestone Action / Supplement Ingested Physiological Rationale & Rules
Clinical Synergy Regimen Exhibit 

      

    


    
    

      
Peer-Reviewed References & Clinical Sources

      
    
        
  1. 
          Forsyth LM, Preuss HG, Donnelly SC, Bellanti JA, et al. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol. 1999;82(2):185-191.
          PMID: 10071523
        
    2. 
        
  2. 
          Castro-Marrero J, et al. Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome? Antioxid Redox Signal. 2015;22(8):679-685.
          PMID: 25386668
        
    3. 
        
  3. 
          Castro-Marrero J, et al. Effect of coenzyme Q10 plus nicotinamide adenine dinucleotide (NADH) supplementation on maximum heart rate and post-exertional malaise in ME/CFS. Clin Nutr. 2021;40(6):3846-3855.
          PMID: 34382894
        
    4. 
        
  4. 
          Naviaux RK, et al. Metabolic features of chronic fatigue syndrome. Proc Natl Acad Sci U S A. 2016;113(37):E5472-E5480.
          PMID: 27573827
        
    5.